News
Genoskin has presented its skin model at Bio Barrier 2014 congress
Genoskin has presented its ex vivo human skin explant model, NativeSkin®, during labcourses focused on skin drug delivery and organized at the Bio Barrier 2014 congress in Saarbrücken, Germany.
Genoskin supported by national and local fundings to innovate in skin cancer models
The State and the Urban Community of Toulouse city launched on 15 March 2013, the first Call for collaborative research and development projects in 2013 OncoSan’Tech on all areas of innovation in relation to cancer.
Oral presentation at Cosminnov 2013
Genoskin will present its technology NativeSkin® at the Cosminnov 2013 congress organized in Orléans, France on October 8th and 9th. Importantly, two of our partners,
Poster presentation at the International Investigative Dermatology annual meeting
We are very pleased to announce that our technology NativeSkin will be presented in a nice study done by LEO Pharma and us at the International Investigative Dermatology annual meeting.
2012 high-talent price of the Toulouse Metropole
GENOSKIN has been awarded the 2012 high-talent price of the Creactiv forum organized by the Grand Toulouse, the joint grouping of local authorities.
GENOSKIN is a new recipient of the Réseau Entreprendre
GENOSKIN is a new laureate of The Réseau Entreprendre Midi-Pyrénées, the local office of the Réseau Entreprendre, a French non profit organization that federate more than 8000 entrepreneurs.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
